$BIO
AI 분석생성일 May 11, 2026
AI Score
Hold$BIO
Bio-Rad Laboratories
$BIONYSEHealthcareLarge-Cap
Bio-Rad manufactures and sells clinical diagnostics products and life science research instruments globally.
Market Cap
$8.0B
Revenue (TTM)
$2.5B
-5.0%
Net Income (TTM)
$0.15B
-20.0%
EPS (TTM)
$5.00
P/E Ratio
62.0
Dividend Yield
0.0%
52-Week Range
$260-$420
Beta
0.62
Dimension Scores
Fundamental
54Technical
52Sentiment
58Risk / Reward
60Momentum
48Financial Health
Profitability
59moderate
Growth
51weak
Liquidity
68strong
Solvency
56moderate
Efficiency
52moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $BIO
Free · No credit card required
면책 조항: AI 생성 분석은 교육 목적으로만 제공됩니다. 투자 조언이 아닙니다. 항상 자격을 갖춘 재무 상담사와 상담하세요.